Patients who suffer from severe and life-threatening rare diseases have few treatment alternatives. They depend on biopharmaceutical companies like Alexion Pharmaceuticals to provide the innovation and development required to deliver life-changing therapies. Alexion’s challenge was to grow awareness of rare diseases and build understanding of the challenges inherent in developing breakthrough therapies for patients in need.
Over the past 15 years, Wyant Simboli has served as a strategic communications partner to Alexion’s founders and senior management. We helped define the company’s core story and developed the Alexion corporate brand to express its mission and values with an integrated suite of brand elements that communicate a cohesive story to both external and internal audiences.
During our brand partnership with Alexion, the company was recognized as a global leader in the biopharmaceutical industry. The Company grew from 200 employees in Connecticut to over 2,500 employees based around the world and has delivered exceptional shareholder value while helping to redefine what it means to live with a rare disease.